Health, Beauty And Wellness News: Executive Moves
This article was originally published in The Rose Sheet
Executive Summary
Ohlhausen exits FTC; Morrow heads HempMeds; and Messing recruits for PainTx advisory board.
You may also be interested in...
Sweeping Change At FTC May Sweep Away RCT Standard For Health Claims
Confirmations by the Senate mark FTC ’s first-ever complete leadership turnover at once and fill out the roster for the first time since President Trump’s election in 2016. The agency has been operating with two commissioners since soon after the election.
FTC Could Open Arms For Health Claim Science In Regulatory Review
FTC is implementing Trump administration directives on "eliminating wasteful, unnecessary regulations and processes," but attempting to reduce regulated industries' compliance burden is not the same as slowing FTC enforcement against false and misleading advertising, attorneys say.
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.